Preventing variceal rebleeding in cirrhotic patients with portal vein thrombosis: A systematic review and meta‐analysis
Journal of Gastroenterology and Hepatology · 2024
DOI: 10.1111/jgh.16489 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Gastroenterology and Hepatology, 2024. Verfasst von Junyuan Zhu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China. Hauptthemen laut MEDLINE: Portal Vein, Portasystemic Shunt, Transjugular Intrahepatic, Liver Cirrhosis, Venous Thrombosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Background and Aim Preventing rebleeding is crucial, but the best prevention technique for patients with cirrhosis and portal vein thrombosis (PVT) remains debatable. Therefore, this systematic review and meta‐analysis compared a transjugular intrahepatic portosystemic shunt (TIPS) with endoscopic therapy (ET) plus nonselective beta‐blockers (NSBBs) for preventing variceal rebleeding in this patient population.
Methods
The PubMed, Embase, Cochrane Library, and Web of Science databases were searched from their inception until May 18, 2023. The studies were screened using predetermined criteria, relevant data were extracted, and pooled analyses were performed using the Reviewer Manager 5.4.1 software.
Results
We retrieved 1032 studies, of which 5 studies comprising a total of 272 patients were included. The postoperative variceal rebleeding rate was significantly lower in the TIPS group than in the ET + NSBBs group (odds ratio [OR] = 0.19, 95% confidence interval [CI] = 0.11–0.35, P < 0.05, I 2 = 0%), but the portal vein recanalization rate was higher (OR = 7.92, 95% CI = 3.04–20.67, P < 0.05, I 2 = 0%). The rates of hepatic encephalopathy (HE) and mortality did not differ between the groups.
Conclusions
Our results suggest that TIPS prevents variceal rebleeding without increasing the hepatic encephalopathy risk more effectively than ET plus NSBBs, but this benefit did not translate into improved survival. Thus, it may be preferable to ET plus NSBBs for preventing variceal rebleeding in patients with cirrhosis and PVT. However, more large‐scale and multicenter randomized controlled trials involving other patient populations are required to verify the clinical efficacy of both these treatments and ensure generalizability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
- Department of Gastroenterology, Shandong Provincial Hospital, Shandong University, Jinan, China.
ORCID-Profile: Chunqing Zhang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Zhu, J., Xia, Y., Liu, X., & Zhang, C. (2024). Preventing variceal rebleeding in cirrhotic patients with portal vein thrombosis: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16489
Vancouver
Zhu J, Xia Y, Liu X, Zhang C. Preventing variceal rebleeding in cirrhotic patients with portal vein thrombosis: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology. 2024. doi:10.1111/jgh.16489
BibTeX
@article{Zhu2024,
author = {Zhu, Junyuan and Xia, Yifu and Liu, Xiao and Zhang, Chunqing},
title = {Preventing variceal rebleeding in cirrhotic patients with portal vein thrombosis: A systematic review and meta‐analysis},
journal = {Journal of Gastroenterology and Hepatology},
year = {2024},
doi = {10.1111/jgh.16489}
}
EUVIMED